261 related articles for article (PubMed ID: 2141079)
21. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
Ransom RW; Asarch KB; Shih JC
J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the in vitro effects of 5-hydroxytryptamine (5-HT) on identified neurones of the rat dorsal motor nucleus of the vagus (DMV).
Browning KN; Travagli RA
Br J Pharmacol; 1999 Nov; 128(6):1307-15. PubMed ID: 10578146
[TBL] [Abstract][Full Text] [Related]
23. A pharmacological analysis of the rat spinal cord serotonin (5-HT) autoreceptor.
Brown L; Amedro J; Williams G; Smith D
Eur J Pharmacol; 1988 Jan; 145(2):163-71. PubMed ID: 2965026
[TBL] [Abstract][Full Text] [Related]
24. 5-HT-mediated synaptic potentials in the dorsal raphe nucleus: interactions with excitatory amino acid and GABA neurotransmission.
Pan ZZ; Colmers WF; Williams JT
J Neurophysiol; 1989 Aug; 62(2):481-6. PubMed ID: 2788717
[TBL] [Abstract][Full Text] [Related]
25. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
[TBL] [Abstract][Full Text] [Related]
26. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
Schoeffter P; Hoyer D
J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
Devivo M; Maayani S
Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
[TBL] [Abstract][Full Text] [Related]
29. Differential inhibition of cholinergic and noncholinergic neurogenic contractions by 5-hydroxytryptamine1A receptor agonists in guinea pig ileum.
Galligan JJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):306-12. PubMed ID: 1346162
[TBL] [Abstract][Full Text] [Related]
30. Presynaptic inhibition of glutamatergic synaptic transmission to rat motoneurons by serotonin.
Singer JH; Bellingham MC; Berger AJ
J Neurophysiol; 1996 Aug; 76(2):799-807. PubMed ID: 8871200
[TBL] [Abstract][Full Text] [Related]
31. Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites.
Marszalec W; Scroggs RS; Anderson EG
J Pharmacol Exp Ther; 1988 Nov; 247(2):399-404. PubMed ID: 2972829
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of N- and P-type calcium currents and the after-hyperpolarization in rat motoneurones by serotonin.
Bayliss DA; Umemiya M; Berger AJ
J Physiol; 1995 Jun; 485 ( Pt 3)(Pt 3):635-47. PubMed ID: 7562606
[TBL] [Abstract][Full Text] [Related]
33. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
Cunningham KA; Appel JB
J Pharmacol Exp Ther; 1986 May; 237(2):369-77. PubMed ID: 2939233
[TBL] [Abstract][Full Text] [Related]
34. Differential actions of cocaine and amphetamine on dorsal raphe neurons in vitro.
Pan ZZ; Williams JT
J Pharmacol Exp Ther; 1989 Oct; 251(1):56-62. PubMed ID: 2795470
[TBL] [Abstract][Full Text] [Related]
35. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors.
Smith BN; Sollars PJ; Dudek FE; Pickard GE
J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775
[TBL] [Abstract][Full Text] [Related]
36. Synaptic responses of guinea pig and rat central amygdala neurons in vitro.
Nose I; Higashi H; Inokuchi H; Nishi S
J Neurophysiol; 1991 May; 65(5):1227-41. PubMed ID: 1678422
[TBL] [Abstract][Full Text] [Related]
37. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
38. 5-HT-1A receptor-mediated modulation of medullary expiratory neurones in the cat.
Lalley PM; Bischoff AM; Richter DW
J Physiol; 1994 Apr; 476(1):117-30. PubMed ID: 8046627
[TBL] [Abstract][Full Text] [Related]
39. Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors.
Muramatsu M; Lapiz MD; Tanaka E; Grenhoff J
Eur J Neurosci; 1998 Jul; 10(7):2371-9. PubMed ID: 9749765
[TBL] [Abstract][Full Text] [Related]
40. Physiological effects of selective 5-HT1a and 5-HT1b ligands in rat hippocampus: comparison to 5-HT.
Segal M; Azmitia EC; Whitaker-Azmitia PM
Brain Res; 1989 Nov; 502(1):67-74. PubMed ID: 2531014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
